Skip to main content
logo
Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
85.46
+2.06 (2.47%)
Feb 26, 2026, 2:47 PM EST - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Transcatheter Aortic Valve Replacement Revenue
4.49B4.11B
Transcatheter Aortic Valve Replacement Revenue Growth
9.29%5.83%
Transcatheter Mitral and Tricuspid Therapies Revenue
550.60M352.10M
Transcatheter Mitral and Tricuspid Therapies Revenue Growth
56.38%78.19%
Surgical Structural Heart Revenue
1.03B981.30M
Surgical Structural Heart Revenue Growth
4.89%5.22%
Revenue (Total)
6.07B5.44B
Revenue (Total) Growth
11.55%8.57%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
3.54B3.21B
United States Revenue Growth
10.51%8.76%
Europe Revenue
1.52B1.32B
Europe Revenue Growth
14.81%11.99%
Japan Revenue
354.70M339.80M
Japan Revenue Growth
4.38%-3.14%
Rest of World Revenue
652.30M572.00M
Rest of World Revenue Growth
14.04%7.70%
Revenue (Total)
6.07B5.44B
Revenue (Total) Growth
11.55%8.57%
Updated Dec 31, 2025. Data Source: Fiscal.ai.